Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Early Human Development

• Publication date

  2011-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.earlhumdev.2011.07.010PMID 21798676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exchange transfusions and top‐up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease

  2011influential reference
• Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn—a prospective randomized controlled trial

  2011cited by this paper
• Intravenous Immunoglobulin in Neonates With Rhesus Hemolytic Disease: A Randomized Controlled Trial

  2011cited by this paper
• Top‐up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions

  2010influential reference
• Recombinant Human Erythropoietin in the Prevention of Late Anemia in Intrauterine Transfused Neonates With Rh-isoimmunization

  2010influential reference
• Prolonged anemia in an intrauterine‐transfused neonate with Rh‐hemolytic disease: no evidence for anti‐D–related suppression of erythropoiesis in vitro

  2009cited by this paper
• Neonatal transfusions

  2009cited by this paper
• Successful Management of Anti-Jra Alloimmunization in Pregnancy: A Case Report

  2009cited by this paper
• Severe fetal thrombocytopenia in Rhesus D alloimmunized pregnancies.

  2008cited by this paper
• Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.

  2008cited by this paper
• Fetal anemia due to non-Rhesus-D red-cell alloimmunization.

  2008cited by this paper
• Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?

  2008cited by this paper
• Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome.

  2008cited by this paper
• The Assessment of Newborn Iron Stores at Birth: A Review of the Literature and Standards for Ferritin Concentrations

  2007cited by this paper
• USE OF RECOMBINANT ERYTHROPOIETIN FOR THE MANAGEMENT OF SEVERE HEMOLYTIC DISEASE OF THE NEWBORN OF A K0 PHENOTYPE MOTHER

  2007cited by this paper
• Urinary excretion of darbepoetin after intravenous vs subcutaneous administration to preterm neonates

  2006cited by this paper
• Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.

  2006cited by this paper
• Intravenous administration of darbepoetin to NICU patients

  2006cited by this paper
• A Case of Rhesus Hemolytic Disease With Hemophagocytosis and Severe Iron Overload Due to Multiple Transfusions

  2006cited by this paper
• Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.

  2005cited by this paper
• Single-Dose Darbepoetin Administration to Anemic Preterm Neonates

  2005cited by this paper
• New insights into erythropoiesis: the roles of folate, vitamin B12, and iron.

  2004cited by this paper
• Late anaemia in Rh haemolytic disease

  2003cited by this paper
• Erythropoietin as Treatment for Late Hyporegenerative Anemia in Neonates with Rh Hemolytic Disease after in utero Exchange Transfusion

  2002cited by this paper
• Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin.

  2002cited by this paper
• Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.

  2002cited by this paper
• SUCCESSFUL TREATMENT OF NEONATAL RHESUS HEMOLYTIC ANEMIA WITH HIGH DOSES OF RECOMBINANT HUMAN ERYTHROPOIETIN

  2001cited by this paper
• Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin.

  2001cited by this paper
• Late hyporegenerative anemia in neonates with rhesus hemolytic disease

  1999influential reference
• Recombinant Erythropoietin in the Prevention of Late Anaemia in Intrauterine Transfused Neonates with Rh-Haemolytic Disease

  1999cited by this paper
• Neutropenia complicating Rh-hydrops fetalis: the effect of treatment with recombinant human granulocyte colony-stimulating factor (rhG-CSF).

  1998cited by this paper
• Management of Late Anemia in Rhesus Hemolytic Disease: Use of Recombinant Human Erythropoietin (A Pilot Study)

  1996cited by this paper
• Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.

  1993cited by this paper
• Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.

  1992cited by this paper
• The Effect of Intrauterine Intravascular Blood Transfusion on Iron Metabolism in Fetuses With Rh Alloimmunization

  1991cited by this paper
• Iron overload, free radical damage, and rhesus haemolytic disease.

  1990cited by this paper
• Neutropenia and thrombocytopenia in infants with Rh hemolytic disease.

  1989influential reference
• Clinical pathological conference.

  1988cited by this paper
• Dietary vitamin E and polyunsaturated fatty acid (PUFA) in newborn babies with physiological jaundice.

  1981cited by this paper
• Coagulation Failure in Babies with Rhesus Isoimmunization

  1979cited by this paper
• Influence of folic acid on birthweight and growth of the erythroblastotic infant. III. Effect of folic acid supplementation.

  1977cited by this paper
• BLOOD COAGULATION STUDIES DURING EXCHANGE TRANSFUSION

  1972cited by this paper
• Megaloblastic anaemia and whole-blood folate levels in premature infants.

  1966cited by this paper
• CLINICAL pathological conference.

  1957cited by this paper
• CLINICAL pathological conference.

  1956cited by this paper

• Hemolytic Disease of the Fetus and Newborn: Protocol for Cohort Studies to Establish Feasibility of Case Ascertainment and Assess Its Impact on Prenatal and Postnatal Outcomes (Preprint)

  2025cites this paper
• Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System

  2024cites this paper
• Effect of Anti-D titers in RhD-negative pregnant women on fetuses and newborns: A retrospective study.

  2023cites this paper
• Premature Atherosclerosis in Children With Transfusion-Dependent Thalassemia

  2023cites this paper
• Iron Overload in Rh-Isoimmunization

  2023cites this paper
• Iron Overload and Anemia in Rhesus Hemolytic Disease of Newborn: A Prospective Observational Study

  2023cites this paper
• Use of blood and its components in the treatment of anaemia in children

  2022cites this paper
• Hyporegenerative anemia in anti‐M‐associated hemolytic disease of the fetus

  2021cites this paper
• Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.

  2021cites this paper
• Hemolytic disease of newborn: fokus pada inkompatibilitas ABO

  2021influential citation
• A comparative study on perinatal outcomes of red blood cell–alloimmunized pregnancies with anti‐RhD in combination and anti‐RhD alone in China

  2021cites this paper
• Early-onset hypoproliferative anemia in an intrauterine-transfused neonate with severe Rh hemolytic disease.

  2021cites this paper
• Severe perinatal hemolytic disease due to anti-e

  2021cites this paper
• Successful Treatment of Severe Hemolytic Disease of the Newborn Caused by Anti-Jkb

  2021cites this paper
• Identification and management of fetal anaemia: a practical guide

  2021cites this paper
• Red cell alloimmunization: A 2020 update

  2020cites this paper
• Hemolytic Disease of Fetus and Newborn in a Primigravida with Multiple Alloantibodies Involving Anti-Jka and Anti-E: A Case Report

  2020cites this paper
• Immunohematologic aspects of alloimmunization and alloantibody detection: A focus on pregnancy and hemolytic disease of the fetus and newborn.

  2020cites this paper
• Haemolytic Disease of Newborn due to Minor Blood Group C IncompatibilityA Case Report

  2019cites this paper
• Hemolytic Disease of the Fetus and Newborn

  2019cites this paper
• Morbus haemolyticus neonatorum

  2019cites this paper
• Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn

  2019cites this paper
• Molecular Detection of Glycophorins A and B Variant Phenotypes and their Clinical Relevance.

  2019cites this paper
• Case 1: Cardiac Arrest in a 2-month-old Boy with a Prenatal Course Complicated by Alloimmunization

  2019influential citation
• Perinatal Transfusion Medicine

  2019cites this paper
• A Newborn Case of “c” Subgroup Mismatch Presenting with Severe Hemolysis and Anemia

  2017cites this paper
• QUESTION 1: Does folic acid supplementation reduce the incidence or severity of anaemia in neonates with a positive direct Coombs test?

  2016cites this paper
• Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.

  2016cites this paper
• The Contribution of IgG Fc Glycans on Antibody-mediated Immune Suppression (AMIS) to Murine Erythrocytes

  2016cites this paper
• Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.

  2015cites this paper
• The long-term effects of fetal anaemia

  2014cites this paper
• Neonatologie

  2013cites this paper
• Role of minor erythrocyte antigens on alloimmunızation in neonatal indirect hyperbilirubinemia background

  2013cites this paper
• Chapter 48 – Perinatal Transfusion Medicine

  2013cites this paper
• Iron status in infants with alloimmune haemolytic disease in the first three months of life

  2013cites this paper
• İndirekt hiperbilirübinemili olgularda minör eritrosit antijenlerinin alloimmünizasyondaki rolü

  2013cites this paper
• Neonatal hemochromatosis: management, outcome, and prevention

  2013cites this paper
• Improving the management and outcome in haemolytic disease of the foetus and newborn.

  2013cites this paper
• Neonatal management and outcome in red cell alloimmunization

  2012cites this paper
• Neonatal Morbidity after Exchange Transfusion for Red Cell Alloimmune Hemolytic Disease

  2012cites this paper
• Fetal Blood Sampling and Intrauterine Transfusion

  2012cites this paper